Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Leukemia

Free Subscription Articles published in Biochem Biophys Res Commun Retrieve available abstracts of 28 articles: HTML format

Single Articles

April 2026
1. LI W, Sun M, Yao B, Li X, et al
   FOSL2 drives acute myeloid leukemogenesis through suppression of ERAD-induced proteostatic collapse.
   Biochem Biophys Res Commun. 2026;809:153493.
   PubMed     Abstract available
   
   
   March 2026
2. CHEN CW, Lin YF, Yeh YY, Huang NK, et al
   Dual-specificity phosphatase 21 enhances the sensitivity of imatinib-resistant chronic myeloid leukemia cells to ponatinib through GATA-1-mediated erythroid differentiation.
   Biochem Biophys Res Commun. 2026;814:153646.
   PubMed     Abstract available
   
   
   February 2026
3. ZHANG W, Liu Y, Xiao X, Zheng Q, et al
   Multi-scale transcriptomics analysis reveals MHC suppression in MEF2D fusion positive B-cell acute lymphoblastic leukemia.
   Biochem Biophys Res Commun. 2026;800:153274.
   PubMed     Abstract available
   
   
   January 2026
4. WANG B, Wang HL, Ye YF, Song JZ, et al
   Ferroptosis regulation and acute leukemia: Mechanisms and therapeutic perspectives.
   Biochem Biophys Res Commun. 2026;800:153284.
   PubMed     Abstract available
   
   
   December 2025
5. TANG BJ, Chen L, Huang ST, Zhong AN, et al
   Exosomal circ_0058493 promotes imatinib resistance via miR-548b-3p/U2SURP axis in CML cells.
   Biochem Biophys Res Commun. 2025;793:153012.
   PubMed     Abstract available
   
   
   
6. SINGH P, Singh VK, Verma M
   Targeting myeloid cell leukemia-1 protein to identify potential compounds for chronic myeloid leukemia treatment: Molecular docking and molecular dynamics simulation approaches.
   Biochem Biophys Res Commun. 2025;796:153115.
   PubMed     Abstract available
   
   
   November 2025
7. SHIMURA R, Yamamoto K, Chang YH, Otaki A, et al
   Development of a CRISPR/Cas9-degron system that enables in vivo specific gene depletion in leukemia models.
   Biochem Biophys Res Commun. 2025;793:153002.
   PubMed     Abstract available
   
   
   
8. MU R, Pei X, Xu N, Liu B, et al
   Regorafenib promotes ferroptosis in acute myeloid leukemia by upregulating NOX4.
   Biochem Biophys Res Commun. 2025;792:152981.
   PubMed     Abstract available
   
   
   
9. TORRES-LOPEZ L, Olivas-Aguirre M, Castellanos-Martinez R, Jimenez-Camacho KE, et al
   Voltage-dependent Kv1.3 potassium channels in the plasma membrane of acute lymphoblastic leukemic B-cells are non-conductive.
   Biochem Biophys Res Commun. 2025;787:152771.
   PubMed     Abstract available
   
   
   August 2025
10. SANSACAR M, Pepe NA, Gencer Akcok EB, El Khatib M, et al
    Efficacy of combinatorial inhibition of Hedgehog and autophagy pathways on the survival of AML cell lines.
    Biochem Biophys Res Commun. 2025;775:152034.
    PubMed     Abstract available
    
    
    July 2025
11. ZHANG X, Zhong L, Zhai L, Li H, et al
    IRF2-driven upregulation of OAS3 promotes AML cell proliferation by modulating the JAK-STAT signaling pathway.
    Biochem Biophys Res Commun. 2025;772:152064.
    PubMed     Abstract available
    
    
    
12. KOYAMA D, Yamamoto N, Abe T, Suzuki K, et al
    Novel insights into the ULK2-FIP200-AMPK-mediated regulation of autophagy and BCR::ABL degradation in chronic myeloid leukemia.
    Biochem Biophys Res Commun. 2025;778:152343.
    PubMed     Abstract available
    
    
    May 2025
13. LI X, Di S, Nie F, Meng W, et al
    RPS15a knockdown impedes the progression of B-ALL by inducing p53-mediated nucleolar stress.
    Biochem Biophys Res Commun. 2025;763:151768.
    PubMed     Abstract available
    
    
    
14. XIMEI WU, Lin C, Wang H, Gao J, et al
    Connectivity-map unveils Gemcitabine's efficacy in overcoming nelarabine resistance in T-cell acute lymphoblastic leukemia.
    Biochem Biophys Res Commun. 2025;769:151971.
    PubMed     Abstract available
    
    
    April 2025
15. FAUZI YR, Nakahata S, Shimoda K, Matsuura T, et al
    Anti-transferrin receptor antibody (JST-TFR09/PPMX-T003) induces ferroptosis in adult T-cell leukemia/lymphoma (ATLL) cells.
    Biochem Biophys Res Commun. 2025;756:151564.
    PubMed     Abstract available
    
    
    March 2025
16. YANG Y, Li Z, Zhang J, Qi H, et al
    Engineering thermostable friend mouse leukemia virus reverse transcriptase through mutational combination.
    Biochem Biophys Res Commun. 2025;760:151716.
    PubMed     Abstract available
    
    
    
17. ROUSSET C, Neplaz R, Catal P, Chatre E, et al
    Correlation-based nanometric localization using lattice SIM(2) and dSTORM in PML nuclear bodies validated by calibration spheres.
    Biochem Biophys Res Commun. 2025;752:151450.
    PubMed     Abstract available
    
    
    December 2024
18. SAWAI S, Oda Y, Saito Y, Kuwabara T, et al
    Analysis of synthetic polymer hydrogel-based generation of leukemia stem cells.
    Biochem Biophys Res Commun. 2024;744:151149.
    PubMed     Abstract available
    
    
    November 2024
19. SHARIPOV RR, Surin AM, Silonov SA, Smirnov EY, et al
    Promyelocytic leukemia protein (PML) knockout increases mitochondrial Ca(2+) uptake in HeLa cells.
    Biochem Biophys Res Commun. 2024;739:150990.
    PubMed     Abstract available
    
    
    September 2024
20. WANG M, Deng Q, Zhang W, Qi Q, et al
    Oxidative lipid damage by naringenin selectively sensitizes chronic myeloid leukemia cell lines and patient samples to Bcr-Abl tyrosine kinase inhibitors.
    Biochem Biophys Res Commun. 2024;733:150653.
    PubMed     Abstract available
    
    
    August 2024
21. FENG X, Luo F, Wang S, Zhu F, et al
    Chidamide induces cell cycle arrest via NR4A3/P21 axis upregulation to suppress relapsed and refractory acute myeloid leukemia.
    Biochem Biophys Res Commun. 2024;737:150493.
    PubMed     Abstract available
    
    
    June 2024
22. NAM H, Kim D, Jin X, Park S, et al
    Metabolic determinants of leukemia onset variability in genetically homogeneous AKR mice.
    Biochem Biophys Res Commun. 2024;725:150257.
    PubMed     Abstract available
    
    
    
23. LIU C, Wang Y, Shi M, Tao X, et al
    hnRNPA0 promotes MYB expression by interacting with enhancer lncRNA MY34UE-AS in human leukemia cells.
    Biochem Biophys Res Commun. 2024;724:150221.
    PubMed     Abstract available
    
    
    May 2024
24. ZHANG S, Lou S, Bian W, Liu J, et al
    Selective eradication of venetoclax-resistant monocytic acute myeloid leukemia with iron oxide nanozymes.
    Biochem Biophys Res Commun. 2024;719:150117.
    PubMed     Abstract available
    
    
    January 2024
25. SUZUKI S, Liu J, Sato Y, Miyake R, et al
    Fucosylation inhibitor 6-alkynylfucose enhances the ATRA-induced differentiation effect on acute promyelocytic leukemia cells.
    Biochem Biophys Res Commun. 2024;710:149541.
    PubMed     Abstract available
    
    
    November 2023
26. LYSIKOVA DV, Vasileva VY, Chubinskiy-Nadezhdin VI, Morachevskaya EA, et al
    Capsazepine activates amiloride-insensitive ENaC-like channels in human leukemia cells.
    Biochem Biophys Res Commun. 2023;687:149187.
    PubMed     Abstract available
    
    
    October 2023
27. NIU F, Yang R, Feng H, Liu Y, et al
    A GPX4 non-enzymatic domain and MDM2 targeting peptide PROTAC for acute lymphoid leukemia therapy through ferroptosis induction.
    Biochem Biophys Res Commun. 2023;684:149125.
    PubMed     Abstract available
    
    
    September 2023
28. DENG Y, Cheng Q, He J
    HDAC inhibitors: Promising agents for leukemia treatment.
    Biochem Biophys Res Commun. 2023;680:61-72.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum